Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial

Sabrina Paganoni; Christina N. Fournier; Eric A. MacKlin; Lori B. Chibnik; Melanie Quintana; Benjamin R. Saville; Michelle A. Detry; Matteo Vestrucci; Joe Marion; Anna McGlothlin; Jeremy M. Shefner; et al.

doi:10.1001/jamanetworkopen.2024.59058

Back

Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial

Journal article

Peer reviewed

Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial

Sabrina Paganoni, Christina N. Fournier, Eric A. MacKlin, Lori B. Chibnik, Melanie Quintana, Benjamin R. Saville, Michelle A. Detry, Matteo Vestrucci, Joe Marion, Anna McGlothlin, …

JAMA network open, Vol.8(2), p.e2459058

02/03/2025

DOI: https://doi.org/10.1001/jamanetworkopen.2024.59058

PMID: 39960672

Files and links (1)

url

https://doi.org/10.1001/jamanetworkopen.2024.59058View

Published (Version of record) Open

Metrics

1 Record Views

Details

Title: Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
Creators: Sabrina Paganoni - Harvard University
Christina N. Fournier - Emory University
Eric A. MacKlin - Harvard University
Lori B. Chibnik - Harvard University
Melanie Quintana - Berry & Associates (United States)
Benjamin R. Saville - Berry & Associates (United States)
Michelle A. Detry - Berry & Associates (United States)
Matteo Vestrucci - Berry & Associates (United States)
Joe Marion - Berry & Associates (United States)
Anna McGlothlin - Berry & Associates (United States)
Jeremy M. Shefner - Barrow Neurological Institute
et al.
Publication Details: JAMA network open, Vol.8(2), p.e2459058
Identifiers: 991006262118102656
Academic Unit: Neurology
Language: English
Resource Type: Journal article